Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Costa

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
BMJ Case Reports|October 18, 2014
Giant colonic diverticulum presenting with painless rectal bleeding and diagnosed at angiographyLuisa Costa Andrade, Marta Baptista, João Filipe Costa, et al.
The Journal of Rheumatology. Supplement|November 3, 2015
Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic ArthritisFabiola Atzeni, Luisa Costa, Francesco Caso, et al.
Critical Reviews in Immunology|May 19, 2020
Pathogenesis of Psoriatic ArthritisFrancesco Caso, Luisa Costa, Maria Sole Chimenti, et al.
RMD Open|October 29, 2015
Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's diseaseFrancesco Caso, Paola Galozzi, Luisa Costa, et al.
Joint Bone Spine|August 13, 2013
Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritisFrancesco Caso, Ugo Fiocco, Luisa Costa, et al.
BMJ Case Reports|May 16, 2014
Aorto-oesophageal fistula treated with emergent thoracic endovascular repairLuisa Costa Andrade, Ricardo Felix-Morais, Alfredo Gil-Agostinho, et al.
Frontiers in Toxicology|October 3, 2022
Fate of engineered nanomaterials at the human epithelial lung tissue barrier <i>in vitro</i> after single and repeated exposuresRoman Lehner, Ilaria Zanoni, Anne Banuscher, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2026
TOGETHER-PsA and the Case for Precision Phenotyping in Psoriatic Arthritis Commentary on: "Ixekizumab with Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults with Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial"Francesco Caso, Luisa Costa, Raffaele Scarpa, et al.
Clinical Rheumatology|April 8, 2014
Efficacy of tocilizumab in a patient with refractory psoriatic arthritisLuisa Costa, Francesco Caso, Luca Cantarini, et al.
The Journal of Rheumatology|September 3, 2017
Psoriatic Disease 10 Years LaterRaffaele Scarpa, Francesco Caso, Luisa Costa, et al.
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
BMJ Case Reports|October 18, 2014
Giant colonic diverticulum presenting with painless rectal bleeding and diagnosed at angiographyLuisa Costa Andrade, Marta Baptista, João Filipe Costa, et al.
The Journal of Rheumatology. Supplement|November 3, 2015
Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic ArthritisFabiola Atzeni, Luisa Costa, Francesco Caso, et al.
Critical Reviews in Immunology|May 19, 2020
Pathogenesis of Psoriatic ArthritisFrancesco Caso, Luisa Costa, Maria Sole Chimenti, et al.
RMD Open|October 29, 2015
Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's diseaseFrancesco Caso, Paola Galozzi, Luisa Costa, et al.
Joint Bone Spine|August 13, 2013
Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritisFrancesco Caso, Ugo Fiocco, Luisa Costa, et al.
BMJ Case Reports|May 16, 2014
Aorto-oesophageal fistula treated with emergent thoracic endovascular repairLuisa Costa Andrade, Ricardo Felix-Morais, Alfredo Gil-Agostinho, et al.
Frontiers in Toxicology|October 3, 2022
Fate of engineered nanomaterials at the human epithelial lung tissue barrier <i>in vitro</i> after single and repeated exposuresRoman Lehner, Ilaria Zanoni, Anne Banuscher, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 9, 2026
TOGETHER-PsA and the Case for Precision Phenotyping in Psoriatic Arthritis Commentary on: "Ixekizumab with Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults with Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial"Francesco Caso, Luisa Costa, Raffaele Scarpa, et al.
Clinical Rheumatology|April 8, 2014
Efficacy of tocilizumab in a patient with refractory psoriatic arthritisLuisa Costa, Francesco Caso, Luca Cantarini, et al.
The Journal of Rheumatology|September 3, 2017
Psoriatic Disease 10 Years LaterRaffaele Scarpa, Francesco Caso, Luisa Costa, et al.
Pageof 22